Traditional Chinese medicine use is associated with lower end-stage renal disease and mortality rates among patients with diabetic nephropathy: a population-based cohort study

Table 3 Mortality associated with the TCM users, by duration of TCM use and TCM use status

	Death	PY	I^a	Before matched		After matched
	Death	PY	I^a	aHR^$ (95% CI)	Sig.	aHR^$ (95% CI)	Sig.
Duration of TCM use (days)
TCM nonuser	14,588	170,815.5	85.4	1 (reference)		1 (reference)
≤ 60	6144	114,886.8	53.5	0.55 (0.54–0.57)	***	0.56 (0.54–0.57)	***
61–120	1236	27,672.5	44.7	0.47 (0.44–0.49)	***	0.47 (0.44–0.50)	***
121–180	566	13,663.0	41.4	0.40 (0.37–0.43)	***	0.43 (0.39–0.46)	***
181–240	311	8969.5	34.7	0.36 (0.33–0.40)	***	0.36 (0.32–0.40)	***
241–	916	32,473.4	28.2	0.29 (0.27–0.30)	***	0.29 (0.28–0.31)	***
TCM use status
Never user	10,699	127,149.0	84.1	1 (reference)		1 (reference)
Former user	3889	43,666.6	89.1	1.01 (0.98–1.05)		1.02 (0.98–1.06)
Current user	5530	113,624.6	48.7	0.49 (0.47–0.50)	***	0.49 (0.48–0.51)	***
New user	3643	84,040.59	43.3	0.47 (0.45–0.48)	***	0.47 (0.46–0.49)	***

*Significance: *p-value <.05; **p-value <.01; ***p-value <.001
^aIncidence is presented as 1000 person-year (PY)
^$Age, gender, geolocation, insured level, comorbidities, medications, previous TCM experience, were adjusted in the Cox regression model to evaluate the hazard ratio for all-cause mortality

ISSN: 2662-7671